Please enable Javascript and disable ad blockers

Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

PlusUltra's profile

Not a member yet? Sign up for free!

Predictions

Pharvaris N.v.

Start price

Target price

Perf. (%)

€16.10

09.01.23

Capable Management

Probably not worthwhile Investment

High valuation

Below average Marketposition

0%

Royalty Pharma Plc

Start price

Target price

Perf. (%)

€36.60

26.12.22

Could be worthwhile Investment >10% per year

Revenue growth >5% per year expected

Undervalued

Very capable Management

0%

Blog